Vascular Pharmaceuticals, Inc.
Biotechnology company · Chapel Hill, North Carolina, United States
Vascular Pharmaceuticals, Inc. is a biotechnology company headquartered in Chapel Hill, North Carolina, United States. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $1.8 million in total, most recently in 2012. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2016.
Vascular Pharmaceuticals at a glance
What does Vascular Pharmaceuticals do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $1.8 million in total (2006 to 2012).
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $3 million sold (2016).
Frequently asked questions about Vascular Pharmaceuticals
Where is Vascular Pharmaceuticals headquartered?
Vascular Pharmaceuticals, Inc. is headquartered in Chapel Hill, North Carolina, United States.
What does Vascular Pharmaceuticals do?
Vascular Pharmaceuticals, Inc. is a biotechnology company.
Similar companies
- BioKier, Inc.Chapel Hill, North Carolina, United States
- Redbud Labs, Inc.Chapel Hill, North Carolina, United States
- Clinical Tools, IncChapel Hill, North Carolina, United States
- OncoTrap, Inc.Chapel Hill, North Carolina, United States
- Areteia Therapeutics, Inc.Chapel Hill, North Carolina, United States
- Falcon Therapeutics, Inc.Chapel Hill, North Carolina, United States
- Chaperone Therapeutics, Inc.Chapel Hill, North Carolina, United States
- Theravida, Inc.Chapel Hill, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences